(Q85833927)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

Aalok Kumar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Hagen F Kennecke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Daniel J Renouf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Howard J Lim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Sharlene Gill

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ryan Woods

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Caroline Speers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Winson Y Cheung

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

20 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

527-534

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Should Dukes' B patients receive adjuvant therapy? A statistical perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Identification of patients with high-risk stage II colon cancer for adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Adjuvant chemotherapy for stage II colon cancer with poor prognostic features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuva

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Revised TN categorization for colon cancer based on national survival outcomes data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Current issues in adjuvant treatment of stage II colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Clinical implications of microsatellite instability in sporadic colon cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29072

7 January 2021

Identifiers

DOI

10.1002/CNCR.29072

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25332117%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference